- Home
- CLMT vs BHVN Comparison
CLMT vs BHVN Comparison
Compare CLMT & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLMT
- BHVN
- Stock Information
- Founded
- CLMT 1916
- BHVN 2013
- Country
- CLMT United States
- BHVN United States
- Employees
- CLMT N/A
- BHVN 256
- Industry
- CLMT Oil & Gas Production
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- CLMT Energy
- BHVN Health Care
- Exchange
- CLMT Nasdaq
- BHVN Nasdaq
- Market Cap
- CLMT 1.4B
- BHVN 1.7B
- IPO Year
- CLMT 2006
- BHVN 2017
- Fundamental
- Price
- CLMT $18.59
- BHVN $15.81
- Analyst Decision
- CLMT Strong Buy
- BHVN Strong Buy
- Analyst Count
- CLMT 6
- BHVN 14
- Target Price
- CLMT $20.38
- BHVN $49.23
- AVG Volume (30 Days)
- CLMT 868.9K
- BHVN 2.5M
- Earning Date
- CLMT 11-07-2025
- BHVN 11-11-2025
- Dividend Yield
- CLMT N/A
- BHVN N/A
- EPS Growth
- CLMT N/A
- BHVN N/A
- EPS
- CLMT N/A
- BHVN N/A
- Revenue
- CLMT $4,070,400,000.00
- BHVN N/A
- Revenue This Year
- CLMT $1.02
- BHVN N/A
- Revenue Next Year
- CLMT $3.05
- BHVN $2,195.07
- P/E Ratio
- CLMT N/A
- BHVN N/A
- Revenue Growth
- CLMT N/A
- BHVN N/A
- 52 Week Low
- CLMT $7.68
- BHVN $12.79
- 52 Week High
- CLMT $25.29
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- CLMT 61.22
- BHVN 57.88
- Support Level
- CLMT $17.93
- BHVN $14.32
- Resistance Level
- CLMT $18.65
- BHVN $15.33
- Average True Range (ATR)
- CLMT 0.78
- BHVN 0.90
- MACD
- CLMT -0.10
- BHVN 0.16
- Stochastic Oscillator
- CLMT 52.68
- BHVN 84.86
About CLMT Calumet Specialty Products Partners L.P. Common Units
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.